UK contract development and manufacturing organization Upperton Pharma Solutions has completed the build of its new sterile ...

The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...

Dr Agarwal's Health Care IPO will open from January 29 to 31, raising ₹3,027.26 crore. The company, which has a 25% market ...

Jubilant Ingrevia has announced the commissioning of its new cGMP compliant facility at Bharuch, Gujarat. The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals ...

The facility is an extension of the company's USFDA-approved plant that is already supplying to the US, Europe, Japan and ...

The Modernization of Cosmetics Regulation Act (MoCRA) introduces significant regulatory changes for the industry aimed at ...

Azzur Cleanrooms on Demand (COD) has entered this acronym-laden environment to provide cleanroom and laboratory spaces for so ...

Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year increase.

Polyrizon (PLRZ) has commenced preliminary work related to the Good Manufacturing Practice – GMP – manufacturing process for its PL-14 allergy ...

IPO Listing Live: Stallion India Fluorochemicals shares debuted at a 33.3% premium on Thursday, listing at Rs 120 on both the ...

The designated manufacturing facility is equipped to meet the clinical trial material ... "By collaborating with Eurofins CDMO Amatsiaquitaine S.A.S., a leader in GMP manufacturing, we are committed ...